Tuesday, November 13, 2012

Sagent Pharma's leucovorin in the FDA shortage list!


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article

My partner blog has an interesting story on why Fusilev sales(at least the current 31% market share) may likely sustain
http://translate.google.com/translate?sl=auto&tl=en&js=n&prev=_t&hl=en&ie=UTF-8&layout=2&eotf=1&u=http%3A%2F%2Fmedicoinvestor.com%2Fsagent-pharma-shortage-af-leucovorin%2F

No comments:

Post a Comment